Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

PHASE3CompletedINTERVENTIONAL
Enrollment

422

Participants

Timeline

Start Date

October 30, 2008

Primary Completion Date

September 1, 2010

Study Completion Date

September 1, 2010

Conditions
Metabolism and Nutrition DisorderObesity
Interventions
DRUG

liraglutide

Liraglutide 3.0 mg per day administered in a 6.0 mg/mL, 3 mL FlexPen® for subcutaneous (under the skin) injection, once daily

DRUG

placebo

Liraglutide placebo 3 mL FlexPen® for subcutaneous (under the skin) injection, once daily

Trial Locations (37)

10065

Novo Nordisk Investigational Site, New York

13760

Novo Nordisk Investigational Site, Endwell

19104

Novo Nordisk Investigational Site, Philadelphia

19107

Novo Nordisk Investigational Site, Philadelphia

23502

Novo Nordisk Investigational Site, Norfolk

27103

Novo Nordisk Investigational Site, Winston-Salem

28401

Novo Nordisk Investigational Site, Wilmington

29406

Novo Nordisk Investigational Site, Charleston

30106

Novo Nordisk Investigational Site, Atlanta

33024

Novo Nordisk Investigational Site, Pembroke Pines

37212

Novo Nordisk Investigational Site, Nashville

40213

Novo Nordisk Investigational Site, Louisville

42431

Novo Nordisk Investigational Site, Madisonville

45236

Novo Nordisk Investigational Site, Cincinnati

45245

Novo Nordisk Investigational Site, Cincinnati

48034

Novo Nordisk Investigational Site, Southfield

59701

Novo Nordisk Investigational Site, Butte

63110

Novo Nordisk Investigational Site, St Louis

75246

Novo Nordisk Investigational Site, Dallas

78681

Novo Nordisk Investigational Site, Round Rock

80909

Novo Nordisk Investigational Site, Colorado Springs

83642

Novo Nordisk Investigational Site, Meridian

85381

Novo Nordisk Investigational Site, Peoria

85395

Novo Nordisk Investigational Site, Goodyear

91763

Novo Nordisk Investigational Site, Montclair

92648

Novo Nordisk Investigational Site, Huntington Beach

33013-3835

Novo Nordisk Investigational Site, Hialeah

R3E 3P4

Novo Nordisk Investigational Site, Winnipeg

L7M 4Y1

Novo Nordisk Investigational Site, Burlington

L8L 5G8

Novo Nordisk Investigational Site, Hamilton

N7T 4X3

Novo Nordisk Investigational Site, Sarnia

H7T 2P5

Novo Nordisk Investigational Site, Laval

J7J 2K8

Novo Nordisk Investigational Site, Mirabel

J1H 4J6

Novo Nordisk Investigational Site, Sherbrooke

G8T 7A1

Novo Nordisk Investigational Site, Trois-Rivières

N5Y 5K7

Novo Nordisk Investigational Site, London

H2W 1R7

Novo Nordisk Investigational Site, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY